Clinical trials referenced in this document:
Documents that mention this clinical trial
A cross-sectional study to validate an administrative back pain severity classification tool based on the graded chronic pain scale
https://doi.org/10.1038/s41598-022-21422-x
Funding for this research was provided by:
Medizinische Hochschule Hannover (MHH)
Article History
Received: 10 February 2022
Accepted: 27 September 2022
First Online: 8 October 2022
Competing interests
: Martin Hochheim (MH) works in part time for Generali Health Solutions GmbH (GHS), which is affiliated with Generali Deutschland Krankenversicherung AG. Max Wunderlich (MW) is managing director of the GHS. Philipp Ramm (PR) is currently responsible for the BP programme. The three declare that the research was conducted in the absence of any commercial or financial relationship that could be construed as a potential conflict of interest. Volker Amelung (VA) declares no conflicts of interest.